Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07102082 · ClinicalTrials.gov registry record · NA

Influence of Authorized Smokeless Tobacco Product Modified Risk Claims I: Consumer Product Demand

A NA study of Smoking Behaviors, sponsored by Roswell Park Cancer Institute.

Recruiting
Registry status
NA
Development phase
160
Enrollment target
1
Study location

NCT07102082 is a NA study of Smoking Behaviors that is actively recruiting participants, run by Roswell Park Cancer Institute. The registered enrollment target is 160 participants, below the 431-participant average among 21 other Smoking Behaviors trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07102082, a NA study of Smoking Behaviors, is actively recruiting participants, sponsored by Roswell Park Cancer Institute.

RECRUITING
Registry status
NA
Development phase
160 participants
Enrollment target
1
Study location

Study Summary

To explore consumer responses to the announcement and implementation of new modified risk claims for Copenhagen and General Snus (brands of smokeless tobacco (ST) products) using a series of complementary and innovative research activities and methods.

Conditions Studied

Interventions

  • BEHAVIORAL Modified Risk - None
  • BEHAVIORAL Modified Risk Claim

Study Locations (1)

New York

  • Roswell Park - Buffalo

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2025-09-25
Est. Completion 2026-11-30
Phase NA

Sponsor

Roswell Park Cancer Institute

365 total trials

What the Registry Record Tells You About NCT07102082

The ClinicalTrials.gov registry entry for NCT07102082 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 431-participant average among 21 other Smoking Behaviors trials with a reported enrollment target (63% lower). The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Smoking Behaviors appearing as the primary indexed condition, and to 2 interventions - of which Modified Risk - None is the first listed.

NCT07102082 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT07102082 about?

NCT07102082 is a clinical study titled "Influence of Authorized Smokeless Tobacco Product Modified Risk Claims I: Consumer Product Demand". To explore consumer responses to the announcement and implementation of new modified risk claims for Copenhagen and General Snus (brands of smokeless tobacco (ST) products) using a series of complementary and innovative research activities and methods.

What is the current status of trial NCT07102082?

This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2025-09-25. Estimated completion is 2026-11-30.

What conditions does trial NCT07102082 study?

This clinical trial studies the following conditions: Smoking Behaviors.

What interventions are being tested in trial NCT07102082?

The interventions under investigation include: Modified Risk - None (BEHAVIORAL), Modified Risk Claim (BEHAVIORAL).

Who is sponsoring clinical trial NCT07102082?

This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07102082 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Smoking Behaviors

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.